Published in Int J Chron Obstruct Pulmon Dis on July 13, 2015
Increased circulating β2-adrenergic receptor autoantibodies are associated with smoking-related emphysema. Sci Rep (2017) 0.75
Longitudinal changes in lung hyperinflation in COPD. Int J Chron Obstruct Pulmon Dis (2017) 0.75
The physiological basis and clinical significance of lung volume measurements. Multidiscip Respir Med (2017) 0.75
Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med (2001) 27.83
Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med (2007) 19.86
The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med (2004) 18.60
The natural history of chronic airflow obstruction. Br Med J (1977) 13.04
The effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trial. Ann Intern Med (2005) 8.86
Cigarette smoking among adults--United States, 2006. MMWR Morb Mortal Wkly Rep (2007) 8.14
Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. Thorax (2004) 8.09
Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax (2005) 7.39
Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH study. Am J Respir Crit Care Med (2008) 6.17
Expansion of the prognostic assessment of patients with chronic obstructive pulmonary disease: the updated BODE index and the ADO index. Lancet (2009) 5.51
Prognostic value of nutritional status in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (1999) 4.74
Chronic obstructive pulmonary disease. Lancet (2012) 4.43
Mortality in COPD: Role of comorbidities. Eur Respir J (2006) 4.14
Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD. Chest (2002) 3.82
Predictors of mortality in patients with emphysema and severe airflow obstruction. Am J Respir Crit Care Med (2006) 3.71
Single breath diffusing capacity in a representative sample of the population of Michigan, a large industrial state. Predicted values, lower limits of normal, and frequencies of abnormality by smoking history. Am Rev Respir Dis (1983) 2.83
Dynamic hyperinflation and exercise intolerance in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2001) 2.83
Lung volumes in healthy nonsmoking adults. Bull Eur Physiopathol Respir (1982) 2.77
Inhaled corticosteroids and mortality in chronic obstructive pulmonary disease. Thorax (2005) 2.69
The 6-min walk distance: change over time and value as a predictor of survival in severe COPD. Eur Respir J (2004) 2.63
Mortality in the 4-year trial of tiotropium (UPLIFT) in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2009) 2.55
Analysis of the factors related to mortality in chronic obstructive pulmonary disease: role of exercise capacity and health status. Am J Respir Crit Care Med (2002) 2.41
Efficacy of salmeterol/fluticasone propionate by GOLD stage of chronic obstructive pulmonary disease: analysis from the randomised, placebo-controlled TORCH study. Respir Res (2009) 2.31
Inspiratory-to-total lung capacity ratio predicts mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2004) 2.02
Deaths from chronic obstructive pulmonary disease--United States, 2000-2005. MMWR Morb Mortal Wkly Rep (2008) 1.84
Using quality of life to predict hospitalization and mortality in patients with obstructive lung diseases. Chest (2002) 1.83
Sex differences in mortality in patients with COPD. Eur Respir J (2008) 1.79
A pooled analysis of FEV1 decline in COPD patients randomized to inhaled corticosteroids or placebo. Chest (2007) 1.79
Inspiratory capacity, dynamic hyperinflation, breathlessness, and exercise performance during the 6-minute-walk test in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2001) 1.76
The 6-min walk distance, peak oxygen uptake, and mortality in COPD. Chest (2007) 1.41
Distance and oxygen desaturation during the 6-min walk test as predictors of long-term mortality in patients with COPD. Chest (2008) 1.41
Sex differences in mortality and clinical expressions of patients with chronic obstructive pulmonary disease. The TORCH experience. Am J Respir Crit Care Med (2010) 1.33
Outcome measures in chronic obstructive pulmonary disease (COPD): strengths and limitations. Respir Res (2010) 1.31
Role of inspiratory capacity on exercise tolerance in COPD patients with and without tidal expiratory flow limitation at rest. Eur Respir J (2000) 1.30
Predictors of mortality in COPD. Respir Med (2010) 1.23
Effects of hyperinflation on the oxygen pulse as a marker of cardiac performance in COPD. Eur Respir J (2008) 1.20
Why does the lung hyperinflate? Proc Am Thorac Soc (2006) 1.17
Standardised mortality rates in females and males with COPD and asthma. Eur Respir J (2005) 1.05
Inspiratory fraction and exercise impairment in COPD patients GOLD stages II-III. Eur Respir J (2006) 0.98
Inspiratory capacity predicts mortality in patients with chronic obstructive pulmonary disease. Respir Med (2007) 0.96
Nutritional status is related to fat-free mass, exercise capacity and inspiratory strength in severe chronic obstructive pulmonary disease patients. Clinics (Sao Paulo) (2010) 0.93
Insights into interventions in managing COPD patients: lessons from the TORCH and UPLIFT studies. Int J Chron Obstruct Pulmon Dis (2009) 0.86
Recent advances in COPD: pathophysiology, respiratory physiology and clinical aspects, including comorbidities. Eur Respir Rev (2009) 0.85
Health status measured with the CRQ does not predict mortality in COPD. Eur Respir J (2002) 0.85
Inspiratory capacity, exercise limitation, markers of severity, and prognostic factors in chronic obstructive pulmonary disease. J Bras Pneumol (2007) 0.77